NCT01719614View on ClinicalTrials.gov

A Study to Explore Pharmacokinetic Interaction Between Rilpivirine and Metformin in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Healthy Participants
Interventions
DRUG

Metformin

Type=exact number, unit=mg, number=850, form=tablet, route=oral. Participants will receive single dose of metformin on Day 1 and Day 15.

DRUG

Rilpivirine

Type=exact number, unit=mg, number=25, form=tablet route=oral. Participants will receive 1 tablet of rilpivirine from Day 5 to Day 17.

Trial Locations (1)

Unknown

Overland Park

All Listed Sponsors
lead

Janssen R&D Ireland

INDUSTRY

NCT01719614 - A Study to Explore Pharmacokinetic Interaction Between Rilpivirine and Metformin in Healthy Participants | Biotech Hunter | Biotech Hunter